Proteins Congress 2010
27th & 28th October 2010, Kempinski Bristol, Berlin, Germany
Proteins Congress 2010 is administered by Osney Media.
Next Event
The Proteins Congress 2010
Wednesday 27th October 2010 to Thursday 28th October 2010
Berlin, Germany
More
Solution Providers
Oxford Global conferences’ strict delegate screening criteria and one to one meeting selection facility allow you to reach a large number of pre-qualified decision makers and make the most of your time at the event.
Read More
Speakers
The Proteins Congress 2010 consists of a unique blend of presentations, panel discussions and one to one business meetings. If you have a cutting edge case study or a thought provoking presentation join us at the event.
Read More
Featured Speakers
Dan Bach-Kristensen,
Senior Pharmaceutical Scientist, Nycomed, Denmark
Hans Baumeister,
COO Glycotope GmbH
Jacques Bellalou,
Head of Platform for recombinant protein production in microorganisms, Structural Biology and Chemistry Department, Institut Pasteur, France
Claudio Belluco,
Senior Scientist, CRO - IRCCS, National Cancer Institute, Aviano
Lorenzo Benatuil,
Senior Scientist, Biologics Abbott Bioresearch Center, USA
Berthold Boedeker,
Head of Cell Culture and Pilot Plants, Global Drug Discovery & Biotech Development Bayer Schering Pharma AG
Anne Bondgaard Tolstrup,
Director, Antibody Expression, Symphogen A/S
Christophe Bonny,
CEO, Xigen, Switzerland
Roland Brock,
Chair, Biochemistry of Integrated Systems; Head, Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University
Konrad Buessow,
Team Leader, Division of Structural Biology, Helmholtz Centre for Infection Research
Robin Butler,
Senior R&D Manager, Protein Science MedImmune
Stefan Dübel,
Professor of Biotechnology, Technische Universitaet Braunschweig, Germany
Rainer Fischer,
Senior Executive Director, Fraunhofer-Institute for Molecular Biology and Applied Ecology IME-MB, Germany
Darren Hart,
Team Leader, EMBL, Grenoble
Judith Hartleib,
Group Leader, AstraZeneca
Bernhard Helk,
Section Head Technology Development Novartis Pharma AG, Basel
Stephen Irving,
Senior Principal Scientist, Pfizer Global Research & Development
Thomas Jostock,
Technology/Platform Leader, Novartis Leading Scientist
Ulrike Korf,
Head of Molecular Genome Analysis Department, DKFZ (German Cancer Research Centre
Debbie Law,
CSO, Ablynx
Melvyn Little,
CSO, Affimed Therapeutics AG, Germany
Ton Logtenberg,
CEO Merus
Paolo Martini,
Director, Protein Expressions and Purification Research, Shire Human Genetic Therapies
Judit Nagy,
Director of Proteomics Facility, Imperial College London
Jo Nettleship,
Senior Scientist OPPF-UK, Research Complex at Harwell, Oxford
Malak K. Pirtskhalava,
Head of the Department of Structural Bioinformatics, Institute of Molecular Biology and Biophysics, Tbilisi State University
Andreas Plückthun,
Professor of Biochemistry, University of Zurich
Rick Rutter,
Vice President of Pharmaceutical Sciences Global Biologics, Pfizer
Irina Rybina,
Senior Scientist Group Leader Gene to Protein, High-throughput Biology, Boehringer Ingelheim Pharmaceuticals, Inc. USA
Herwig Schüler,
Team Leader, Structural Genomics Consortium, Karolinkska Institutet, Stockholm
Manfred Schuster,
COO, APEIRON Biologics AG, Vienna, Austria
Arne Skerra,
Professor of Biological Chemistry, Technische Universitaet Muenchen, Freising-Weihenstephan, Germany & Founder and CEO, XL-protein GmbH
Young-Hwa Song,
Head of moleulcar Biol & Biochem Lab, EMBL-Hamburg, Germany
Willem 'Pim' Stemmer,
CEO, Amunix Inc.
Michael Sundstrom,
Managing Director NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen
Yvonne Thielmann,
Research Scientist, Department of Molecular Membrane Biology, Max Planck Institute for Biophysics
Barbara Valsasina,
Senior Scientist, Biology Department, Nerviano Medical Sciences
Jan van de Winkel,
President Research & Development and Chief Scientific Officer, GenMab A/S
Dmitry Veprintsev,
Senior Scientist, Paul Scherrer Institute, Switzerland
Peter Vorstheim,
Senior Vice President, BU HESylation® Technology; Kabi Innovation Centre, Fresenius Kabi Deutschland GmbH
Paul Watt,
CSO & CEO Phylogica
Florian Wurm,
Professor of Biotechnology, Laboratory of Cellular Biotechnology, EPFL; Founder and CSO, ExcellGene SA, Switzerland
Zhenping Zhu,
Vice President and Global Head, Protein Sciences and Design, Novartis
Eugene Zhukovsky,
Senior Research Fellow, Boehringer Ingelheim
Media Sponsors
Home | Book Online | About The Event |  |  | Event Format |  | Speakers | Delegates | Solution Providers | Media Partners | Submit A Poster | Press Centre | Testimonials | Venue | Organisers | Other Events | Contact | White Papers/News | 
© Proteins Congress 2010